Procedure for the detection in vivo of neurotrypsin, use of the method and use of the C-terminal fragment of 22 kDa agrin as biomarker in the diagnosis and monitoring of neurotrypsin-related disorders activity.

摘要

Procedure for the detection in vivo of neurotrypsin activity, wherein the amount of the 22kDa fragment of agrin in a sample taken from a patient is measured, and the measured amount of the 22kDa fragment of agrin used in the sample to calculate the activity of neurotrypsin, the sample being blood or urine.